ACBDs have recently been considered key regulators in the development and progression of some cancers, including breast cancer, hepatocellular carcinoma, etc. [5–7] Acyl-CoA-binding domain-containing 3 (ACBD3) is a part of the ACBD family and a 528 amino acid residue protein [8]. This evidence concerns the gene ACBD3 and breast cancer.